Accepted for/Published in: JMIR Infodemiology
Date Submitted: Jan 2, 2021
Date Accepted: Jul 18, 2021
Public attitude and factors of COVID-19 testing hesitancy in the United Kingdom and China: a comparative infodemiology study
ABSTRACT
Background:
Background:
Massive community-wide testing has become a cornerstone of management strategies for the COVID-19 pandemic. This study aimed to assess public attitudes, risk perception, information needs, perceived access, and uptake experience about COVID-19 testing in the UK and China.
Objective:
This study aimed to assess public attitudes, risk perception, information needs, perceived access, and uptake experience about COVID-19 testing in the UK and China.
Methods:
Methods We collected and manually coded 3856 UK tweets and 9299 Chinese Sina Weibo posts mentioning COVID-19 testing from June to July, 2020. We adopted a grounded theory framework to conduct content analysis. Descriptive analysis, time trends, geographical mapping, and chi-squared test were performed to assess the temporal, spatial, and socio-demographic characteristics that determine the difference of attitudes or uptake of COVID-19 tests.
Results:
Results Social media users in the UK demonstrated a higher percentage of support towards COVID-19 testing than those in China; comparatively, there were much wider reports of public uptake of COVID-19 tests in mainland China than the UK, and uncomfortable experiences and logistical barriers to testing were more expressed in China. The top reasons for taking COVID-19 tests were personal health needs, community-wide testing, and mandatory testing policies for travel, with major differences in the ranking order between two countries. Rumours and information need about COVID-19 testing were also identified.
Conclusions:
Conclusion The local epidemic situation influenced public attitudes towards individual COVID-19 testing and mass community-wide testing. Policies and information campaigns that emphasise the importance of timely testing and provide a supporting environment for accessing a test are key to normalise COVID-19 testing as a part of life during the pandemic and to increase uptake.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.